Recent advances in cannabinoid therapeutics for Dravet syndrome

Find out more

Register now - Save up to nearly 1/3 on tickets when you register by 23 September 2022
Submit an abstract - Deadline 5 August 2022
 

---

The recent approval of Epidiolex (cannabidiol) for the treatment of seizures in Dravet syndrome and other infantile epileptic encephalopathies has led to cannabinoids being investigated for their potential as antiepileptic agents.

We invite you to our upcoming focussed meeting, Recent advances in cannabinoid therapeutics for Dravet syndrome, where you will explore and hear updates on these recent biomedical advances.

If you have any questions, please contact meetings@bps.ac.uk.

 

---

Find out more

Register now - Save up to nearly 1/3 on tickets when you register by 23 September 2022
Submit an abstract - Deadline 5 August 2022